PAX7 and neoplasm: Therefore, in our current studies we aimed to perform a comparative analysis of the cells of two subclones of the ARMS RH30 cell line, PAX7 negative (PAX7−) and PAX7 positive (PAX7+), to identify novel molecular factors influencing tumor progression, based on the differences between these subclones and in comparison to other RMS cell lines.